Takeda Pharmaceutical TAK Balance Sheet (2017-2026)

NYSE TAK
$20.08 +0.47 (+2.37%)
As of: Oct 20, 2026 · 3:59 PM EDT
Reported Financials

Takeda Pharmaceutical Quarterly Balance Sheet

Periods 33 quarters
Latest Jun 2026

Takeda Pharmaceutical reported total assets of $96.73B and total liabilities of $50.05B for the quarter ended Jun 2026, down 0.2% year over year. This balance sheet covers 33 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2017 Dec2017 Mar2018 Dec2018 Mar2019 Jun2019 Sep2019 Nov2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
5,925.00M6,295.17M6,963.51M4,729.45M5,526.08M5,154.69M4,005.45M2,185.25M2,129.75M2,038.88M3,022.98M5,005.21M6,016.23M3,147.40M2,573.99M2,421.92M4,586.20M4,187.23M3,722.79M2,846.92M
Short-term InvestmentsInvestments (Current)
2,342.32M2,001.56M207.38M2,083.01M2,277.17M2,069.30M151.46M2,024.51M2,097.62M1,906.29M99.64M2,237.23M1,832.75M2,532.02M136.86M2,333.10M2,459.12M2,710.64M262.06M2,860.25M
Cash & Current Investments
8,267.32M8,296.72M7,170.90M6,812.46M7,803.25M7,223.99M4,156.91M4,209.75M4,227.37M3,945.17M3,122.62M7,242.43M7,848.98M5,679.42M2,710.85M4,755.02M7,045.32M6,897.87M3,984.85M5,707.17M
Receivables - NetNet Receivables
7,484.08M6,218.46M5,821.16M5,579.70M5,261.29M5,321.54M5,065.21M5,476.55M5,057.87M5,064.20M4,745.61M4,701.22M4,906.31M4,531.47M5,152.46M4,605.91M4,636.52M4,708.46M6,114.55M5,745.80M
Receivables
7,484.08M6,218.46M5,821.16M5,579.70M5,261.29M5,321.54M5,065.21M5,476.55M5,057.87M5,064.20M4,745.61M4,701.22M4,906.31M4,531.47M5,152.46M4,605.91M4,636.52M4,708.46M6,114.55M5,745.80M
Raw Materials
Work In Process
Inventory
7,048.88M7,051.13M6,991.97M6,790.52M6,601.42M6,976.48M7,405.78M7,482.90M7,739.98M8,270.10M7,989.10M7,945.50M8,449.40M7,939.28M8,136.43M8,584.98M8,745.15M8,996.64M8,737.56M8,937.95M
Prepaid Assets
1,206.02M1,202.40M1,156.35M1,196.12M1,077.58M1,164.83M1,207.71M1,242.46M1,193.40M1,268.42M1,115.13M1,226.05M1,129.01M1,141.82M1,066.74M1,202.21M1,119.73M1,123.85M1,017.50M1,165.85M
Current Assets
22,404.29M21,535.10M21,255.70M18,665.59M19,009.88M19,530.73M18,002.54M17,074.30M16,486.64M17,173.37M16,895.01M19,339.04M21,389.19M17,543.79M16,850.97M17,389.80M19,654.90M19,924.42M19,334.86M19,455.35M
Non-Current Assets
Buildings
Construction in Progress
Land & Improvements
Property, Plant & Equipment (Net)PP&E (Net)
13,137.67M12,980.60M12,971.54M12,485.39M12,188.01M12,462.13M12,696.82M12,400.30M12,683.63M13,020.57M13,139.04M12,977.91M13,220.20M12,852.49M13,154.98M13,536.60M13,352.58M13,323.58M13,267.18M13,230.24M
Long-Term Investments
1,047.19M908.26M791.49M710.83M670.71M710.42M744.54M693.61M690.47M730.48M593.18M545.71M109.45M80.84M72.20M68.83M60.02M65.14M55.03M62.24M
Goodwill
36,720.81M36,223.57M36,122.87M35,241.56M34,581.44M35,292.58M35,966.12M35,793.12M35,497.01M36,140.05M35,724.16M35,682.48M36,139.54M35,173.81M35,587.07M36,645.32M36,553.71M36,782.54M36,342.43M36,356.20M
Intangibles
34,888.78M32,954.77M31,294.16M30,347.17M28,990.00M28,331.86M32,054.24M31,178.92M29,479.77M28,968.55M28,226.90M27,171.75M26,408.05M25,173.03M24,272.38M23,682.63M22,202.80M22,476.57M21,392.18M20,942.99M
Goodwill & Intangibles
71,609.59M69,178.34M67,417.03M65,588.73M63,571.44M63,624.44M68,020.36M66,972.04M64,976.78M65,108.60M63,951.06M62,854.23M62,547.58M60,346.84M59,859.44M60,327.94M58,756.51M59,259.12M57,734.61M57,299.19M
Long-Term Deferred Tax
3,108.13M3,065.41M2,971.12M2,822.77M2,733.15M2,703.91M2,747.75M2,593.74M2,251.36M2,239.19M2,600.80M2,375.00M2,369.36M2,396.66M2,477.96M2,775.16M2,623.02M2,733.08M3,417.52M3,329.64M
Other Non-Current Assets
859.66M692.19M677.02M619.94M558.74M502.38M475.41M415.41M399.58M386.78M338.18M660.28M595.42M472.36M469.75M474.37M474.65M497.39M481.79M495.92M
Non-Current Assets
92,104.55M88,826.35M86,742.25M84,310.67M81,999.23M82,072.57M86,784.59M85,099.61M83,099.44M83,391.91M82,872.50M81,650.36M-11,213.96M5,309.52M78,381.15M79,516.02M77,725.89M4,748.04M77,708.50M77,277.47M
Assets
114,508.83M110,361.44M107,997.95M102,976.27M101,009.11M101,603.31M104,787.12M102,173.91M99,586.09M100,565.28M99,767.51M100,989.40M102,063.97M96,225.00M95,232.12M96,905.81M97,380.80M98,513.39M97,043.35M96,732.83M
Liabilities
Current Liabilities
Accounts Payables
2,900.85M3,052.11M4,231.21M3,106.82M2,690.67M2,867.29M4,874.08M3,045.48M2,819.65M3,419.83M3,615.43M2,917.98M2,894.85M2,931.18M3,178.39M2,915.28M2,954.24M2,989.48M3,073.96M2,759.24M
Notes Payables
Payables
2,900.85M3,052.11M4,231.21M3,106.82M2,690.67M2,867.29M4,874.08M3,045.48M2,819.65M3,419.83M3,615.43M2,917.98M2,894.85M2,931.18M3,178.39M2,915.28M2,954.24M2,989.48M3,073.96M2,759.24M
Accumulated Expenses
Other Accumulated Expenses
4,681.49M4,683.63M4,793.84M4,441.62M4,477.56M4,814.76M4,254.39M3,864.81M3,858.92M4,137.71M4,088.58M3,512.31M3,496.16M3,604.41M3,985.40M3,577.30M3,401.75M3,630.50M3,692.12M3,534.55M
Short term Debt
4,492.21M4,012.51M3,278.65M3,725.50M3,796.58M3,788.42M3,942.44M3,422.39M3,849.51M3,833.18M3,372.11M3,835.95M3,909.44M3,765.60M5,133.50M3,703.13M3,672.82M3,635.53M4,087.67M3,684.04M
Current Taxes
262.41M268.32M1,646.59M194.50M190.28M189.23M1,744.56M33.20M26.95M29.00M725.74M1,009.42M990.59M1.45M892.26M2.74M15.53M20.91M612.36M728.32M
Current Deferred Revenue
Curent Deferred Tax LiabilityCurent Deferred Tax
Total Current Liabilities
3,711.95M3,663.05M17,584.92M3,403.85M3,934.25M3,560.10M18,633.04M3,645.34M4,403.84M3,411.35M15,274.06M3,516.92M4,370.98M3,575.90M16,752.92M3,487.96M3,711.59M3,728.25M17,718.07M6,145.22M
Non-Current Liabilities
Non-Current Debt
39,639.83M36,779.32M33,940.21M31,630.34M28,860.96M29,453.82M30,350.68M29,909.20M29,492.78M30,360.41M29,559.57M31,379.28M31,005.74M29,967.08M26,509.86M28,611.16M29,284.04M27,300.63M27,337.67M27,296.91M
Pension
1,455.39M1,475.74M1,195.26M1,019.65M943.83M999.19M957.91M947.01M903.68M982.43M950.09M925.26M951.70M907.27M905.17M979.21M969.76M962.80M898.91M875.66M
Minority Interest
3.48M4.28M4.13M4.03M3.88M3.91M4.12M4.26M4.51M4.76M4.89M5.07M5.84M5.98M6.37M6.68M7.33M7.56M6.11M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
5.46M8.83M1.08M9.31M8.92M4.91M5.01M5.12M14.63M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
4,967.29M4,854.79M3,700.27M3,344.38M3,224.70M2,924.26M2,031.67M1,861.78M1,531.56M940.65M751.30M345.45M326.50M239.94M234.95M231.90M222.28M200.00M167.69M166.99M
Other Non-Current Liabilities
2,109.47M1,645.17M550.84M1,022.40M782.93M1,358.56M490.90M2,167.99M2,059.39M1,754.22M534.46M1,645.67M1,415.83M1,373.22M553.81M1,419.35M1,522.06M1,728.33M624.48M719.83M
Total Non-Current Liabilities
51,674.21M48,299.13M43,834.78M40,860.54M37,967.18M38,305.37M38,446.69M37,086.12M36,382.46M36,754.38M36,461.20M37,110.96M36,868.30M35,604.25M32,120.98M34,381.92M34,987.42M32,954.42M32,837.53M32,977.69M
Total Liabilities
66,558.78M64,023.16M61,402.01M56,725.23M54,526.78M55,134.12M57,079.73M54,365.73M52,236.65M52,890.76M51,735.25M52,452.60M53,587.63M48,967.50M48,873.89M49,394.59M49,386.65M49,642.19M50,555.60M50,050.92M
Shareholder's Equity
Total Debt
44,132.04M40,791.83M37,218.86M35,355.85M32,657.54M33,242.24M34,293.12M33,331.59M33,342.28M34,193.58M32,931.67M35,215.23M34,915.17M33,732.68M31,643.36M32,314.29M32,956.86M30,936.16M31,425.34M30,980.95M
Common Equity
47,950.05M46,338.28M46,595.95M46,251.04M46,482.33M46,469.18M47,707.39M47,808.18M47,349.44M47,674.52M48,032.26M48,536.80M47,257.50M46,358.23M47,511.22M47,994.15M48,871.20M46,487.75M46,681.91M
Liabilities and Shareholders Equity
114,508.83M110,361.44M107,997.95M102,976.27M101,009.11M101,603.31M104,787.12M102,173.91M99,586.09M100,565.28M99,767.51M100,989.40M102,063.97M96,225.00M95,232.12M96,905.81M97,380.80M98,513.39M97,043.35M96,732.83M
Treasury Shares
0.27M0.21M
Retained Earnings
14,172.03M12,748.89M12,126.73M10,687.27M10,594.68M11,343.40M11,570.08M10,292.15M9,682.92M9,876.53M9,186.50M8,327.94M8,222.86M7,937.51M8,003.85M7,730.13M7,004.93M4,456.81M4,119.28M

Takeda Pharmaceutical Balance Sheet API

Pull Takeda Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TAK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY